BidaskClub upgraded shares of LifePoint Health, Inc. (NASDAQ:LPNT) from a sell rating to a hold rating in a report released on Wednesday morning.

A number of other equities analysts have also recently weighed in on LPNT. Mizuho boosted their price target on LifePoint Health from $50.00 to $57.00 and gave the stock a neutral rating in a report on Tuesday, February 21st. Cantor Fitzgerald reissued a neutral rating on shares of LifePoint Health in a report on Tuesday, February 21st. Zacks Investment Research raised LifePoint Health from a sell rating to a hold rating in a report on Wednesday, February 22nd. TheStreet raised LifePoint Health from a c+ rating to a b- rating in a report on Monday, March 13th. Finally, Deutsche Bank AG started coverage on LifePoint Health in a report on Tuesday, April 4th. They issued a hold rating and a $68.00 price target for the company. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have issued a buy rating to the company. LifePoint Health currently has an average rating of Hold and a consensus target price of $65.46.

Analyst Recommendations for LifePoint Health (NASDAQ:LPNT)

Shares of LifePoint Health (NASDAQ LPNT) opened at 65.40 on Wednesday. The stock has a market cap of $2.64 billion, a price-to-earnings ratio of 17.26 and a beta of 0.94. The firm has a 50-day moving average price of $62.59 and a 200 day moving average price of $61.46. LifePoint Health has a 52-week low of $50.60 and a 52-week high of $70.95.

LifePoint Health (NASDAQ:LPNT) last released its quarterly earnings results on Friday, April 28th. The company reported $1.07 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.01 by $0.06. LifePoint Health had a return on equity of 7.06% and a net margin of 2.26%. The company had revenue of $1.63 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the previous year, the firm posted $0.85 earnings per share. The business’s revenue for the quarter was up 3.1% compared to the same quarter last year. Analysts expect that LifePoint Health will post $4.20 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This story was first reported by Daily Political and is the property of of Daily Political. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this story can be viewed at https://www.dailypolitical.com/2017/06/20/lifepoint-health-inc-lpnt-rating-increased-to-hold-at-bidaskclub.html.

In related news, EVP John P. Bumpus sold 33,333 shares of the company’s stock in a transaction on Thursday, March 30th. The stock was sold at an average price of $65.00, for a total value of $2,166,645.00. Following the completion of the transaction, the executive vice president now directly owns 143,829 shares in the company, valued at $9,348,885. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Richard H. Evans sold 2,000 shares of the company’s stock in a transaction on Thursday, May 11th. The shares were sold at an average price of $62.88, for a total value of $125,760.00. Following the completion of the transaction, the director now owns 17,718 shares of the company’s stock, valued at $1,114,107.84. The disclosure for this sale can be found here. Insiders sold 117,680 shares of company stock valued at $7,574,965 over the last quarter. Insiders own 7.28% of the company’s stock.

Institutional investors have recently added to or reduced their stakes in the stock. BlackRock Inc. raised its position in LifePoint Health by 11,671.9% in the first quarter. BlackRock Inc. now owns 3,745,824 shares of the company’s stock valued at $245,351,000 after buying an additional 3,714,004 shares during the last quarter. Dimensional Fund Advisors LP raised its position in LifePoint Health by 0.5% in the first quarter. Dimensional Fund Advisors LP now owns 3,388,830 shares of the company’s stock valued at $221,969,000 after buying an additional 18,327 shares during the last quarter. Vanguard Group Inc. raised its position in LifePoint Health by 3.8% in the first quarter. Vanguard Group Inc. now owns 3,266,963 shares of the company’s stock valued at $213,986,000 after buying an additional 120,201 shares during the last quarter. Wellington Management Group LLP raised its position in LifePoint Health by 5.5% in the first quarter. Wellington Management Group LLP now owns 3,257,272 shares of the company’s stock valued at $213,351,000 after buying an additional 168,451 shares during the last quarter. Finally, Alliancebernstein L.P. raised its position in LifePoint Health by 4.2% in the first quarter. Alliancebernstein L.P. now owns 1,725,943 shares of the company’s stock valued at $113,049,000 after buying an additional 68,886 shares during the last quarter. Hedge funds and other institutional investors own 99.80% of the company’s stock.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.